IP Library › Granted Patent US 9,763,786
Granted Patent B2
US 9,763,786 · App. 14/880,546 · Granted Sep 19, 2017

Device for regulating blood flow

Inventors: Menno Kalmann (Elspeet, NL); Peter W. J. Hinchliffe (Campbell Hall, NY); Adam I. Lehman (Northford, CT)
Assignee: Deep Vein Medical, Inc.
A61F2/2475A61F2/91
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,763,786
App. No.
14/880,546
Granted
Sep 19, 2017
Kind
B2
Abstract

An implantable device for regulating blood flow through a blood vessel comprising an elongated support dimensioned and configured to be implanted in a blood vessel. The support includes a linking member linking axially spaced apart portions to one another. A valve membrane extends between the axially spaced apart support portions and includes first region folded over the first linking member and attached thereto and a second region adjacent the first region and unattached to the first linking member. The second region is movable between a first position to enable blood flow and a second position to inhibit blood flow.

Claims (22)

1. An implantable device for regulating blood flow through a blood vessel, comprising:

a) an elongated support dimensioned and configured to be implanted in a blood vessel, the support including axially spaced apart first and second substantially annular support portions and a first linking member linking the axially spaced apart portions to one another; and

b) a valve membrane extending between the axially spaced apart support portions and having an upper portion, a lower portion and an intermediate portion, the valve membrane including a first region and a second lower region, the first region folded over the first linking member for attachment and the second region being adjacent the first region and unattached to the first linking member, the second region movable between a first position to enable blood flow and a second position to inhibit blood flow.

2. The implantable device of claim 1 , further comprising a third region folded over for attachment to the first linking member, the second region positioned between the first and third region.

3. The implantable device of claim 1 , wherein the first linking member is curved and traverses a longitudinal axis of the device.

4. The implantable device of claim 1 , wherein the support is formed at least in part from a shape memory alloy material.

5. The implantable device of claim 1 , wherein the valve membrane is formed at least in part from ePTFE.

6. The implantable device of claim 1 , wherein the valve membrane is coated at least in part with an anti-clotting agent.

7. The implantable device of claim 1 , further comprising a second linking member, the valve membrane having a fourth region folded over the second linking member for attachment.

8. An implantable device of claim 1 , wherein the upper portion of the valve membrane is attached to a bottom region of the first support portion and the lower portion of the membrane is attached to a top region of the second support portion.

9. The implantable device of claim 8 , wherein a section of the lower portion of the membrane is wrapped around a section of the top region of the support portion.

10. The implantable device of claim 1 , wherein the support is integrally formed from a laser cut tube.

11. An implantable device for regulating blood flow through a blood vessel, comprising:

a) an elongated support dimensioned and configured to be implanted in a blood vessel; and

b) a valve membrane supported by the support and including first, second, third, and fourth portions, the first portion attached at a first region of the support, the third portion attached at a second region of the support, the second portion positioned between the first and third portions and unattached to the support, the second portion movable with respect to the support between a first position to enable blood flow and a second position closer to the support to inhibit blood flow, and the fourth portion separate from the second portion and unattached to the support, the fourth portion movable with respect to the support between a first position to enable blood flow and a second position to inhibit blood flow.

12. The implantable device of claim 11 , wherein the first and a third portions of the valve membrane form a flap wrapped around a portion of the support, and the second portion forms a flap movable with respect to the first and third portions to create an opening for antegrade blood flow.

13. The implantable device of claim 12 , wherein the second portion of the valve membrane is closer to a top region than a bottom region of the valve membrane.

14. The implantable device of claim 11 , wherein the support includes a first and second linking members extending between first and second annular portions of the support, and the second portion forms a first flap adjacent the first linking member and the fourth portion forms a second flap adjacent the second linking member, the flaps each creating a space between the flap and the respective linking member during antegrade blood flow to enable blood flow through the space and the flap closing the space during retrograde blood flow.

15. An implantable device for regulating blood flow through a blood vessel, comprising:

a) an elongated support dimensioned and configured to be implanted in a blood vessel and engagable with a blood vessel wall, the support including axially spaced apart first and second support portions, and a first linking member linking the axially spaced apart first and second support portions to one another, wherein the first linking member comprises first and second connecting members each having a first end connected to the first support portion and a second end connected to the second support portion, wherein the first ends of the first and second connecting members extend from and share a common point of the first support portion and the second ends of the first and second connecting members extend from separate points of the second support portion; and

b) a valve membrane attached to the linking member, the valve membrane having an upper portion attached to a first section of the support and a lower portion attached to a second section of the support, the valve membrane having an enabling condition to enable blood flow when blood flows in one direction and an inhibiting condition to inhibit blood flow when blood flows in an opposite direction, the upper attached portion of the membrane and the lower attached portion of the membrane remaining substantially fixed in position in both the enabling condition and the inhibiting condition and the lower and upper attached portions remaining adjacent opposing regions of the vessel wall in both conditions.

16. The implantable device of claim 15 , wherein the valve membrane includes an intermediate portion between the upper and lower attached portions, and further includes a first flap in the intermediate portion, the first flap unattached to the support and movable for creating the flow inhibiting and flow enabling conditions while the upper and lower attached portions remain substantially fixed in position.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2017
From: KALMANN, MENNO; HINCHLIFFE, PETER W.J.; LEHMAN, ADAM I.
To: INTERVENTIONAL & SURGICAL INNOVATIONS LLC
Reel/Frame 041616/0459 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2017
From: INTERVENTIONAL & SURGICAL INNOVATIONS LLC
To: DEEP VEIN MEDICAL, INC.
Reel/Frame 041616/0485 →
Continuity (8)
Continuation 13344928 · Jan 6, 2012
Continuation 12319176 · Jan 2, 2009
Continuation In Part 11801489 · May 10, 2007
Continuation In Part 11801691 · May 10, 2007
Provisional Application 61010012 · Jan 4, 2008
Provisional Application 60809483 · May 31, 2006
Provisional Application 60808406 · May 25, 2006
Related Publication 20160262888A1 · Sep 15, 2016